Hooks is a Managing Director of Inova Strategic Investments and the Inova Personalized Health Accelerator. He is responsible for leading Inova's innovation investing and development for companies that are transforming Inova and global health services.
Hooks has been the CEO of a venture-backed company, the President of a public software company, managed four venture capital funds totaling $650 million and served on 20 corporate boards of directors. Prior to joining Inova, Hooks was a General Partner and co-founder of Valhalla Partners, an information technology venture capital firm. He raised, invested and helped manage two funds totaling $440 million. Valhalla invested in 43 companies. He was also a Managing Director of FBR Technology Venture Partners, where he raised, invested and managed two funds totaling $210 million. FBR Technology Venture Partners invested in 30 companies. Prior to that, Hooks was the CEO of Roadshow International, a leading provider of supply chain software. Roadshow had over 1,400 customers in 40 countries. Hooks merged Roadshow with Descartes Systems Group (NASDAQ: DSGX) and became President of the combined company.
Mr. Johnston is a graduate of Brown University and Harvard Business School.
Pete is a Managing Director of Inova Strategic Investments and the Inova Personalized Health Accelerator. He is responsible for leading Inova's innovation investing and development for companies that are transforming Inova and global health services.
Pete has been a corporate officer for publicly traded high technology companies, founder of a venture funded startup company and CEO of a non-profit innovation investment and consulting company. Prior to joining Inova Strategic Capital, Pete served as the CEO of the Center for Innovative Technology (CIT) where he created CIT's seed stage venture funds, a portfolio of three funds containing over 135 companies, CIT's research commercialization fund, a portfolio of 90 research investments and MACH37, the first cyber security accelerator.
Prior to CIT, he was Senior Vice President of ArcSight during company formation and product development. In 2008, ArcSight completed a successful initial public offering and was sold to Hewlett Packard for $1.5 billion. Prior to ArcSight, Pete was COO of Condor Technology Solutions (CNDR), a web and e-business solutions provider acquired by CACI. Pete began his career at Electronic Data Systems (EDS), where he worked for 20 years. His last position at EDS was Vice President and General Manager, responsible for large-scale integration, software development, and outsourcing services for government clients. Pete has 36 years of experience in the technology industry with experience in all aspects of business operations, including market assessment, strategic planning, product development, sales, merger and acquisition, and operational delivery.
Mr. Jobse is a graduate of the Indiana University of Pennsylvania.
Mike is a Director of Inova Personalized Health Accelerator. He is responsible for identifying and investing in all IPHA companies and expediting their achievement of value creating milestones.
As a healthcare technology CEO, Mike raised $125 million in capital and drove shareholder returns that ranged from 4x to 80x, including one IPO and one acquisition. Mike was most recently the founder and CEO of Appian Medical, a digital health firm that served the sleep apnea market. Previously, Mike was CEO of iSonea Ltd (ASX:ISN), a publicly traded global, mobile health app developer and medical device manufacturer in the respiratory disease market, where he increased the company’s market capitalization from $4MM to $250MM.
Earlier in his career, Mike was President and CEO of Sleep Solutions, a VC-backed medical device manufacturer, EVP of Sales and Marketing for National Sleep Technologies (NST, acquired by GE Medical), and Vice President of Sales at Patient InfoSystems (NASDAQ: PATI). Mike began his career in sales and marketing at Merck and GlaxoWellcome.
He is currently a member of the Board of Directors for Circadiance LLC, a specialty CPAP mask manufacturer and is a former board member of AdvaMed, the global medical device association.
Mike graduated from Cornell University with a degree in Microbiology.